ABSTRACT The human erythrocyte contains two types of cyclic AMP-dependent protein kinase. The membrane-associated protein kinase holoenzyme can be released intact by hypotonic treatment at alkaline pH. Chromatography on DEAEcellulose and molecular weight determinations demonstrate that this enzyme is a type I cyclic AMP-dependent protein kinase, while the predominant cyclic AMP-dependent protein kinase found in the cytoplasm is type II. The catalytic subunits of the two types of kinase found in the erythrocyte are identical, but the regulatory subunits, which distinguish the two types of kinase, determine their localization within the cell. It is proposed that the regulatory subunit of the type I enzyme, in addition to binding the catalytic subunit, interacts specifically with one or more membrane proteins and that this interaction may serve to position the kinase in preferential proximity to protein substrates. These and other observations indicate that the two protein kinases are selective as mediators of cAMP action. Yet, in the presence of the same substrates, activation of either would be expected to have similar consequences owing to their ability to phosphorylate the same substrates. This apparent paradox implies that other regulating factors must confer selectivity on the response of cAMP-dependent protein kinases to changes in the intracellular level of cAMP. This paper describes some studies on the subcellular localization of the cAMP-dependent protein kinases of the human erythrocyte, a cell for which only two well-defined and easily separable compartments exist: the membrane and the cytoplasm. A hypothesis concerning possible factors that may play a role in determining the selective activity of the two types of enzyme is proposed.
that the regulatory subunit of the type I enzyme, in addition to binding the catalytic subunit, interacts specifically with one or more membrane proteins and that this interaction may serve to position the kinase in preferential proximity to protein substrates.
Many hormonal effects in mammals are mediated by changes in intracellular concentrations of adenosine 3',5'-cyclic monophosphate (cAMP). It is also believed that cAMP-dependent protein kinases are the major, if not the only, receptors responsible for the various effects of this cyclic nucleotide (for reviews, see refs. [1] [2] [3] . In these kinases, the regulatory subunit inhibits the catalytic subunit; complexing of cAMP with the former subunit promotes holoenzyme dissociation, producing a free, active, cAMP-independent catalytic subunit. This subunit catalyzes the transfer of the terminal phosphoryl group of ATP to seryl and threonyl side chains of various protein substrates, thus modifying their function.
The different cAMP-dependent protein kinases in mammalian tissues, referred to as type I and type II, are conveniently distinguished by their order of elution from DEAE-cellulose by a salt gradient. They differ in size, charge, affinity for cAMP, rates of dissociation and association, and the effect of MgATP on the dissociation constant for cAMP (3) (4) (5) ; yet their catalytic subunits seem to be identical (3, 4, 6, 7) . The relative amounts of type I and type II vary greatly among different tissues of the same species and within the same tissues among different species (5, 8) . Several recent studies suggest that the two protein kinases are separately regulated and have distinct functions. BALB 3T3 cells, for instance, contain predominantly the type II enzyme, but after transformation with simian virus 40, type I appears (9) . The relative amounts of the two kinases also change during the different phases of the cell cycle (10) , in the course of development in the rat testes (11) , and in steroid-responsive tissues in rats subjected to castration, hypophysectomy, or adrenectomy (12) .
These and other observations indicate that the two protein kinases are selective as mediators of cAMP action. Yet, in the presence of the same substrates, activation of either would be expected to have similar consequences owing to their ability to phosphorylate the same substrates. This apparent paradox implies that other regulating factors must confer selectivity on the response of cAMP-dependent protein kinases to changes in the intracellular level of cAMP. This paper describes some studies on the subcellular localization of the cAMP-dependent protein kinases of the human erythrocyte, a cell for which only two well-defined and easily separable compartments exist: the membrane and the cytoplasm. A hypothesis concerning possible factors that may play a role in determining the selective activity of the two types of enzyme is proposed.
MATERIALS AND METHODS Materials. cAMP, ATP, theophylline, EDTA, ethylene glycol bis(f3-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), dithiothreitol, phenylmethylsulfonyl fluoride, Triton X-100, protamine sulfate, and arginine-and lysine-rich histones were from Sigma. DEAE-cellulose (Sephacel) (17) (18) (19) (20) (21) (22) (23) (24) . The catalytic subunit, but not the holoenzyme or the regulatory subunit, can be eluted from the membrane by high salt concentrations (17) or by micromolar concentrations of cAMP at physiologic ionic strength (25) . The intact holoenzyme or the regulatory subunit can be obtained by solubilization of the membrane with detergents (24) . Two milliliters (8.4 mg of protein) of membranes were solubilized and the 35,000 X g supernatant (Triton X-100 extract) was collected. Triton X-100 was removed by addition of the extract to an equal volume of packed SM-2 BioBeads that had been washed with phosphate/EDTA/dithiothreitol and stirring gently for 18 hr at 4VC.
Samples were then centrifuged as above and aliquots were assayed. Results are for 100-gl samples. Detergent depletion was monitored by the disappearance of Triton X-100 fluorescence at 360 nm (excitation at 278 nm). Similar treatment of soluble protein kinases with SM-2 Bio-Beads did not affect their activity. (26) . These results suggest that the protein kinase is not itself an intrinsic membrane protein (see ref. 27 ), but that it may be associated with the membrane, probably through hydrophobic interaction with an intrinsic membrane protein.
DEAE-cellulose chromatography of the protein kinase released from the membrane by hypotonic treatment and of a cytoplasmic preparation is shown in Fig. 1 . The data demonstrate that (i) the membrane-associated cAMP-dependent protein kinase is a type I enzyme, as has been reported (26); (ii) the predominant cytoplasmic protein kinase is a type II enzyme; and, therefore, (iii) the two enzymes are compartmentalized with the cell. The small amount of type I enzyme found in the cytoplasm could be a membrane-derived contaminant released into the cytoplasmic fraction during hypotonic lysis of the erythrocytes since it was found to be identical in every respect to the membrane-associated enzyme (data not shown).
Molecular weights of the cAMP-binding subunits were estimated by photoaffinity labeling of intact membranes and of the type II cytoplasmic enzyme (after DEAE-cellulose chromatography and gel filtration on an S-200 Sephacryl column) with the cAMP analog 8-azido-[32P]cAMP (28, 29) . After sodium dodecyl sulfate/polyacrylamide gel electrophoresis of the two labeled preparations, autoradiographs (Fig. 2) indicated that the Mr is 47,000 for the cAMP-binding subunit of the membrane protein kinase and 54,000 for the cytoplasmic enzyme. These values agree with those reported by Walter et al. (30) for the regulatory subunits of type I and type II cAMP-.dependent protein kinases, respectively, from several tissues. The incorporation of the photolabel was completely eliminated if 1 MM cAMP was included in the prephotolytic reaction mixture, indicating that the labeled sites are indeed the specific cAMP-binding sites. The Mrs provide additional evidence for the classification of the two protein kinases as type I and type II. Fig. 2 also indicates that the membrane contains a single type of protein kinase regulatory subunit, as is also concluded from Scatchard analysis (31) of [3H]cAMP-binding studies (25) .
Mr determinations by gel filtration (Fig. 3) 4 the membrane-derived type I and the cytoplasmic type holoenzymes yielded the values 170,000 and 185,000, respe tively, similar to those found in other species (3) (4) (5) . When the membraneassociated enzyme was prepared by solubilization of the membrane with Triton X-100 (rather than by elution from the membrane by hypotonic-alkaline treatment as in Fig. 3 ) and 0.1% Triton X-100 was included in the Sephacryl S-200 (or Bio-Gel A-0.5 m) column buffer, the enzyme was eluted in the Biochemistry: Dreyfuss et al. 5928 Biochemistry: Dreyfuss et al. (Fig. 2) , the catalytic subunits, and the holoenzymes (Fig. 3) are consistent with an R2C2 model, as found in all other mammalian species studied. As further evidence that the catalytic subunits of the two cAMP-dependent protein kinases of the human erythrocyte are functionally indistinguishable, in the presence of cAMP the two enzymes showed identical relative substrate specificity for three commonly used substrates (Table 2) and their Km values were also identical for protamine, ATP, and Mg2+ (Table 3) differ for the two types of enzyme) determine the intracellular localization of the enzymes, and, hence, the protein substrates available to them. The regulatory subunit may then interact not only with the catalytic subunit, but also with the substrate(s), either directly or indirectly, through other protein(s) which might be termed "matchmaking" protein(s) (34) .
The recent identification by Srivastava and Stellwagen (35) of fragments of the regulatory subunit of Mr as low as 10,000, which still bind cAMP and regulate the catalytic subunit, implies that only a relatively small portion of the regulatory subunit is necessary for the cAMP-dependent regulation of the enzymatic activity. It also suggests that the regulatory subunit has a significant amount of polypeptide chain(s) that is not involved in its cAMP-dependent regulatory function. Yet this portion seems to be evolutionarily conserved, at least with respect to charge and size; in all mammaln species studied, both the type I and the type II protein kinases have regulatory sub- units that have (for each type) a similar size and elute from DEAE-cellulose at similar salt concentrations. Some of this "extra material" of the regulatory subunit could constitute asubstrate-tinding domain; that is, the domain to which a substrate or a substrate-binding "matchmaking" protein (34) can bind.
We have found recently (25) that the human erythrocyte membrane, depleted of most of its type I protein kinase by hypotonic treatment at alkaline pH, reconstitutes specifically with type I, but not with type II, cAMP-dependent protein kinase from rabbit skeletal muscle. Furthermore, pretreatment of the depleted membrane with proteases abolishes its binding capacity. These findings support the idea that the regulatory subunit binds to other protein(s) in addition to the catalytic subunit, suggesting that the human erythrocyte contains an intrinsic binding protein specific for the type I regulatory subunit.
Though the regulatory subunit may position the enzyme in preferential proximity to some substrate(s), it is possible that, during prolonged elevation of cAMP level and in the absence of additional compartnent-maintaining barriers, the dissociated catalytic subunit may diffuse away to phosphorylate other proteins. Still, preferential accessibility and relative proximity could allow the designated substrate(s) to be preferentially and more rapidly phosphorylated.
